???pagination.result.count???
???pagination.result.page???
1
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist. , Yuan Y , Yan Z, Lao Q, Jiang N, Wu S , Lu Q, Han J , Zhao S., Eur J Med Chem. February 5, 2023; 247 115036.
Xenopus GLP-1-based glycopeptides as dual glucagon-like peptide 1 receptor/ glucagon receptor agonists with improved in vivo stability for treating diabetes and obesity. , Li Q , Yang Q, Han J , Liu X, Fu J, Yin J., Chin J Nat Med. November 1, 2022; 20 (11): 863-872.
Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease. , Han C, Sun Y, Yang Q, Zhou F, Chen X, Wu L, Sun L, Han J ., Mol Pharm. August 2, 2021; 18 (8): 2906-2923.
Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/ glucagon receptor agonists. , Jiang N, Jing L, Li Q , Su S, Yang Q, Zhou F, Chen X, Han J , Tang C , Tang W., Eur J Med Chem. February 15, 2021; 212 113118.
Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents. , Han J , Huang Y, Chen X, Zhou F, Fei Y, Fu J., Eur J Med Chem. September 5, 2018; 157 177-187.
A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates. , Park CR, Moon MJ, Park S, Kim DK, Cho EB, Millar RP, Hwang JI, Seong JY., PLoS One. June 11, 2013; 8 (6): e65420.
Cloning, tissue distribution, and functional characterization of chicken glucagon receptor. , Wang J , Wang Y, Li X, Li J, Leung FC., Poult Sci. December 1, 2008; 87 (12): 2678-88.